| |
|
|
|
Arca Biopharma Inc  
|
|
4.49 0.42 (0.1%) |
09-25 16:00 |
|
Open: |
4.16 |
Pre close: |
4.07 |
Target:
|
5.88
|
|
High: |
4.5499 |
Low: |
4.16 |
Resistance:
|
5.03
5.76
|
|
Volume: |
677,479 |
Market Cap: |
27M |
Support:
|
3.85
3.20
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.40
 |
MACD |
MACD(12,26):
|
-0.36  |
|
MA(20): |
4.76 |
Signal(12,26,9): |
-0.36 |
|
MA(100): |
6.19 |
Stochastic Oscillator |
%K(14,3):
|
21.70 |
|
MA(250): |
5.31 |
%D(3): |
25.43 |
|
Average Volume(K) |
3-Month: |
104795
|
52-Week |
High:
|
22.00 |
|
10-Days: |
148609 |
Low: |
2.21 |
|
RSI |
RSI(14):
|
40.70 |
Change(%): |
-16.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.074 |
Return on Equity (ttm) |
-51.3 |
Shares Out. (M) |
4.48 |
|
EPS Est. Current Year |
-1.750 |
Return on Assets (ttm) |
-29.4 |
Shares Float (M) |
5.90 |
|
EPS Est. Next Year |
-1.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.57 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.28 |
|
Forward EPS |
-0.570 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
67 |
|
Book Value (p.s.) |
4.550 |
EBITDA (p.s.) |
-1.152 |
P/E |
-1.46 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.99 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-4.77 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.11 |
P/CF |
-4.22 |
|
|
|
|
|
|
